Applicability of the linear-quadratic formalism for modeling local tumor control probability in high dose per fraction stereotactic body radiotherapy for early stage non-small cell lung cancer

• Verfasst von: Guckenberger, Matthias [VerfasserIn]
• Verfasst von: Sterzing, Florian [VerfasserIn]
• Titel: Applicability of the linear-quadratic formalism for modeling local tumor control probability in high dose per fraction stereotactic body radiotherapy for early stage non-small cell lung cancer
• Verf.angabe: Matthias Guckenberger, Rainer Johannes Klement, Michael Allgäuer, Steffen Appold, Karin Dieckmann, Iris Ernst, Ute Ganswindt, Richard Holy, Ursula Nestle, Meinhard Nevinny-Stickel, Sabine Semrau, Florian Sterzing, Andrea Wittig, Nicolaus Andratschke, Michael Flentje
• E-Jahr: 2013
• Jahr: 30 October 2013
• Umfang: 8 S.
• Fussnoten: Gesehen am 16.02.2021
• Titel Quelle: Enthalten in: Radiotherapy and oncology
• Ort Quelle: Amsterdam [u.a.] : Elsevier Science, 1983
• Jahr Quelle: 2013
• Band/Heft Quelle: 109(2013), 1, Seite 13-20
• ISSN Quelle: 1879-0887
• DOI: doi:10.1016/j.radonc.2013.09.005
• Datenträger: Online-Ressource
• Sprache: eng
• Sach-SW: Biologically effective dose
• Sach-SW: Dose-response modeling
• Sach-SW: Linear-quadratic formalism
• Sach-SW: Non-small cell lung cancer
• Sach-SW: Stereotactic body radiotherapy
• K10plus-PPN: 1746014202

Abstract

Background and purpose - To compare the linear-quadratic (LQ) and the LQ-L formalism (linear cell survival curve beyond a threshold dose dT) for modeling local tumor control probability (TCP) in stereotactic body radiotherapy (SBRT) for stage I non-small cell lung cancer (NSCLC). - Materials and methods - This study is based on 395 patients from 13 German and Austrian centers treated with SBRT for stage I NSCLC. The median number of SBRT fractions was 3 (range 1-8) and median single fraction dose was 12.5Gy (2.9-33Gy); dose was prescribed to the median 65% PTV encompassing isodose (60-100%). Assuming an α/β-value of 10Gy, we modeled TCP as a sigmoid-shaped function of the biologically effective dose (BED). Models were compared using maximum likelihood ratio tests as well as Bayes factors (BFs). - Results - There was strong evidence for a dose-response relationship in the total patient cohort (BFs>20), which was lacking in single-fraction SBRT (BFs<3). Using the PTV encompassing dose or maximum (isocentric) dose, our data indicated a LQ-L transition dose (dT) at 11Gy (68% CI 8-14Gy) or 22Gy (14-42Gy), respectively. However, the fit of the LQ-L models was not significantly better than a fit without the dT parameter (p=0.07, BF=2.1 and p=0.86, BF=0.8, respectively). Generally, isocentric doses resulted in much better dose-response relationships than PTV encompassing doses (BFs>20). - Conclusion - Our data suggest accurate modeling of local tumor control in fractionated SBRT for stage I NSCLC with the traditional LQ formalism.